Acrivon Therapeutics shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $43k | 24k | 1.78 |
| 2026-03-31 | $33k | 24k | 1.39 |
| 2025-12-31 | $116k | 48k | 2.41 |
| 2025-03-31 | $27k | 13k | 2.03 |
| 2024-09-30 | $264k | 38k | 7.00 |
| 2024-03-31 | $93k | 13k | 7.15 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management